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Summary
Mechanisms involved in self-antigen processing and presentation are crucial in understanding
the induction ofself-tolerance in the thymus. We examined the immunogenicity of determinants
from major histocompatibility complex (MHC) molecules that are expressed in the thymus and
have tested peptides derived from the polymorphic regions of class I and class II molecules. We
found that two peptides corresponding to NH2 termini of the class II ac and (3 chains (A.,1-18
and A' 1-16) could bind to self-Ak molecules with high affinity and, surprisingly, were immu-
nogenic in that they could elicit strong proliferative T cell responses in B10.A mice (Ak,Ek).
Neonatal injection of peptide Ak 1-16 resulted in complete unresponsiveness to this peptide at
8 wk of age showing that these T cells were susceptible to tolerance induction. We have also
tested certain class I MHC peptides and showed that some can interact efficiently with class
II MHC peptides to induce an autoreactive T cell proliferative response. Among these class I
peptides is one (Dd 61-85) that has the capacity to bind to self-la without being immunogenic,
and therefore represents an MHC determinant that had induced thymic self-tolerance. We conclude
that some self-MHC molecules can be processed into peptides that can be presented in the context
ofintact classII molecules at the surface ofantigen-presenting cells. Autoreactive T cells recognizing
optimally processed self-peptide/MHC complexes are eliminated during development, whereas
other potentially autoreactive T cells escape clonal inactivation or deletion. Incomplete tolerance
to self-antigens enriches the T cell repertoire despite the fact that such T cells may eventually
become involved in autoimmune disease.
C
lass I and Class II molecules encoded within the MHC
have been shown to play critical roles in the immune
system by acting as peptide binding molecules for presenta-
tion to cytotoxic and helper T lymphocytes (1-3). During
an immune challenge, the peptides presented to T lympho-
cytes are derived from foreign antigens by ill-defined processing
pathways. It has been hypothesized by I{ourilsky et al. (4)
that most self-cellular proteins are processed and presented
as peptides in the context of class I or class II MHC mole-
cules for interaction with T lymphocytes. The self-peptides,
which have access to and can bind efficiently to self-MHC
molecules, should be continuously presented at the cell sur-
face of the APC and may contribute to the acquisition of
the T cell repertoire in ontogeny and to the regulation of
the T cell response (5-7). Likewise, in the adult animal, it
has been shown recently that self-molecules such as hemo-
globin are regularly processed and presented to induce T cell
responses in the periphery (8). Mechanisms of self-antigen
processing and presentation must also be important in the
induction of self-tolerance in the thymus, where self-antigens
presented to developing T cells cause deletion of autoreactive
cells. One would therefore predict that examination ofa panel
of peptides derived from self-class I and -class II proteins
from the MHC, expressed in the thymus, would reveal a subset
of peptides thatbindswith high affinity to MHC molecules
but is not immunogenic because of the deletionof the corre-
sponding T cells. In this study, we have tested a number of
peptides derived from the polymorphic regions of the a1 and
01 domains of the Ak murine class II molecule and the a1
and c12 domains of the Ld and Dd class I MHC molecules.
We found that certain MHC peptides bound to self-class II
MHC molecules with high affinity and were immunogenic,
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thermore, one class I-derived peptide, although able to bind
to self-Ia molecules, was not immunogenic, suggesting that
it represents an MHC determinant that had induced thymic
self-tolerance.
Materials and Methods
Peptide Synthetic and Purification.
￿
Peptides were synthesized in
the Norris Cancer Center Microchemistry Laboratory, USC, with
an automated peptide synthesizer (model 430A; Applied Biosystems,
Foster City, CA) using modified Merrifield chemistry. They were
cleaved from the resin and deprotected by using either hydrogen
fluoride (Peninsula Laboratories, Inc., Belmont, CA), or trifluoro-
methane sulfonic acid. They were then chromatographed on
Sephadex G10 with 30% acetic acid and lyophilized. Each peptide
(< 100 mg) was then purified by reverse-phase HPLC at room tem-
perature on a 20-14M, 300-A , 25 x 1-cm Aquapore octyl prep
10 cartridge column (Brownlee Labs, Santa Clara, CA), using 0.1%
trifluoroacetic acid with a gradient of 80% aqueous acetonitrile
containing0.1% trifluoroacetic acid. Each peptide chromatographed
essentially as a sharp single peak. All purified peptides were found
to have the expected amino acid composition. Peptides were dis-
solved at a concentration of 1 mg/ml in PBS and further diluted
to appropriate concentrations with assay medium.
T Cell Proliferation Assay.
￿
B10.A mice (H-2') were obtained
from The Jackson Laboratory, Bar Harbor, ME, and were bred at
UCLA. Mice ofeither sex were used at 3-8 mo of age. Mice were
immunized in both foot pads and at the base of their tails with
50 feg ofMHC peptide emulsifiedin CFA (Difco Laboratories, Inc.,
Detroit, MI). Popliteal and inguinal LN cells were obtained 10 d
later, and used in antigen-induced proliferation assays. A 5 x 10,
LN cell suspension was prepared and washed in DMEM sup-
plemented with 2 mM glutamine, 501AM 2-ME, 100 U/ml peni-
cillin, 100,ug/ml streptomycin, and 10% FCS. Then the cells were
cultured in 0.2 ml ofHL-1 medium alone, containing 2 mM gluta-
mine, orwith 50 Ftg/ml (final concentration) ofcontrol lysozome
(HEL) or specific peptide (20 Pg/ml of immunizing peptide) in
96-well culture dishes for 4 d (5 x 105 cells/well). Antigen-
induced proliferation was assessed by the incorporation of 1 tiCi
['H]thymidine during the last 18 h of culture.
Competition for MHC Binding.
￿
105 A04H.H4.3 T hybridomas
cells specific for the HEL peptide, 20-35 in association with I-Ak,
were cocultured for 24 h with CH27 (Ak, Ek) B lymphoma cells
(105 cells) as APC, in the presence of the HEL peptide 20-35 (10
FM) and various concentrations of the known competitor (HEL
46-61) or of different MHC-derived peptides. The 96-well micro-
plates were then centrifuged, and the culture supernatants (100 wl)
were aspirated and transferred to a new microtiter tray which was
frozen and thawed before assay for IL;-2 production . 11,2 was as-
sayed by ['H]thymidine incorporation of the I1,2-dependent cell
line HT2. Briefly, 0.04 ml of culture supernatants was further in-
cubated with 10' HT-2 for 24 h in total volume of 0.2 ml com-
plete DMEM. Incorporation of 1 p.Ci ['H]thymidine was assayed
during the last 4 h of culture.
Tolerance Induction.
￿
Tolerance was induced to the peptide A$,
1-16 by two intraperitoneal injections of 10 nmol of peptide
in IFA, the first within 24 h afterbirth and the second between
72 and 96 h after birth. 8 wk later, tolerant animals were im-
munized with peptide in CFA for LN proliferation as described
in the legend for Fig. 2.
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Immunogenicity ofMHC Peptides.
￿
Immunization of natu-
rally recombinant B10.A mice (Kk, Ak, Ek, Dd, Ld) with the
class II-derived peptide Ak n 1-18 or Ak k 1-16 induces strong
and specific T cell proliferative responses. Three other Ak-
derived peptides from other polymorphic regions (whose se-
quences are indicated in Fig. 1) were found to be nonimmuno-
genic (Fig. 2). Immunization of B10.A mice with the class
I peptide Ld 61-85, constituting the a1 helix in the native
molecule, triggers specific LN cell proliferation that is class
II-MHC restricted. T cell responses to these peptides were
blocked by anti-CD4 but not anti-CD8 mAbs (data not
shown). Two other class I peptides, Dd 61-85 and Ld 148-
162 (at a corresponding portion of the cO helix), were un-
able to induce T cell proliferation (Fig. 3). Thus, Ak 1-18,
Ap 1-16, and Ld 61-85 are all self-MHC peptides that had
not induced self-tolerance, but on the contrary, were highly
immunogenic.
Binding to Ak MHC Molecules: Class II Peptides.
￿
To de-
termine whether the class II-derived peptides were being
presented to T cells in association with the self-molecule Ak,
we showed that each of the immunogenic class II peptides
was capable of inhibiting the in vitro 11,2 production of an
Ak-restricted HEL20-35-specific T cell hybridoma in re-
sponse to the appropriate 20-35 peptide. As shown in Fig.
4, among the five la peptides tested, only A0' 1-18 and AO
1-16 show a strong and dose-dependent inhibitory activity
and their inhibition potency is comparable to that observed
with the known HEL46-61 competitor (9). The other three
MHC class II e tides Aa 1-18
EDDIEADHVHSYGITVYQSRGDIGQYTFEFDGDELFYVD
A« 49-63
￿
_At 68-81
LDKKETVWMLREFAQLRRFENQGGLQNIATHKHNLEILT
KRSNSTPATN.
Ap 1-16
GNSERHFVHQFQPFCYFTNGTQRIRLVIRYIYNREEYVR
As 58-71 _
FDSDVGEYRAVTELGRPDAEYWNKQYLERTRAELDTV
CRHNYEKTETPTSLRR
MHC Class i e tide
L d 61-85
￿
ERITQIAKGQEQWFRVNLRTLLGYV
Dd 61-85 ERETRRAKGNEQSFRVDLRTALRYY
L d 148-162
1
EOAGAAEYYRAYLEG
Figure 1 .
￿
Amino acid sequences of MHC-derived peptides used inthis
study.Figure 2.
￿
Ak 1-18 and As 1-16 peptides induce T cell proliferative re-
sponses in B10.A mice (Ak, Ek). Results are expressed as stimulation in-
dices ± SD; i.e., ratio ofcpm obtainedwith cells stimulated in vitro with
the relevant MHC peptide (/) or control antigen (HEL) (U) vs. cpm
of cells treated with medium alone. The response to MHC-derived pep-
tides of four individual mice in each group (starting from the left) aver-
aged 30,291 ± 3,928; 1,959 ± 209; 2,150 t 344; 32,396 ± 4,042; and
2,052 ± 263 cpm. The positive control responses to purified proteinderiva-
tive (PPD) ranged from 110,008 to 183,770 cpm. The background values
(cells without antigens) ranged from 1,134 to 2,529 cpm.
peptides show no inhibition at all. Inhibition under these
conditions can be directly attributed to competitive binding
to the appropriate MHC restriction element by the extrinsic
peptide (10). Lamont et al. (11) demonstrated a close correla-
tion between binding of peptide to class II molecule and in-
hibition of activation ofan unrelated hybridoma. In the case
of Ak k 1-16, no inhibition of an I-Ek-restricted HEIJl-17 re-
Figure 3.
￿
Ld 61-85 induces T cell proliferative responses in B10.A (H-
22) mice. Results are expressed as stimulation indices ± SD; i.e., ratio
of cpm obtained with cells stimulated in vitro with the relevant MHC
peptide (/) or control antigen (HEL) (0) vs. cpm of cells treated with
medium alone. The responses to class I MHC-derived peptides of four
individual mice in each group (starting from theleft) were 78,620 ± 8,630;
2,110 ± 418; and 1,698 ± 389 cpm. The positive control responses to
PPD ranged from 110,008 to 183,770 cpm. The background values (cells
without antigens) ranged from 2,152 to 3,800 cpm.
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Figure 4.
￿
Ak k , 1-18 and AAk 1-16 peptides competitively inhibit the Ak-
restricted response of a T cell hybridoma to p20-35 from HEL. Results
are expressed as % inhibition; i.e., 100 x cpm obtained with HEL 20-35
+ MHC peptide/cpm obtained with HEL 20-35. The following peptides
were tested in this inhibition assay: Ak n 1-18 (A), Ak, 49-63 (l]), Aka 68-
81 (O), Ak 1-16 (/), A~ 58-71 (A), and HEL p46-61 (") (used as posi-
tive control). The responses to p20-35 rangedfrom 78,949 to 93,897 cpm.
sponse was observed (data not shown), confirming that com-
petition is for the Ak molecule. We interpret these results
as demonstrating class II-restricted T cell responses to self
Ak peptides.
Binding to Ak MHC Molecules: Class IPeptides.
￿
It was of
interest to determine whether the self-peptide Dd 61-85
could bind to class II molecules of the k haplotype despite
the absence of a response after immunization. We tested this
class I peptide for its capacity to competitively inhibit an Ak-
restricted HEIrspecific T cell response. In fact, Dd 61-85
completely blocked the in vitro 11,2 production of an Ak-
restricted T cell hybridoma in response to the relevant HEL
peptide, to a comparable extent as the prototype high-binding
HEL peptide p46-61 (Fig. 5). Likewise, immunogenic Ld 61-
85 bound, while the nonimmunogenic, truncated Ld 61-72
failed to inhibit. We conclude therefore that Dd 61-85 is
capable of binding to the Ak molecule, but is incapable of
triggering a T cell response in B10.A mice displaying the
Ak restriction element. It is noteworthy that the same class
I peptide, Dd 61-85, when seen as an allopeptide in the con-
text of the same Ia molecule (Ak) in CBA/J and B10.BR
mice (H-2k), induces a T cell proliferative response (Table
1). This confirms that this peptide can be efficiently presented
by the Ak molecule and can induce an in vivo T cell response
in mice whose T cells, specific for this class I peptide/Ak de-
terminant, have not been rendered tolerant.
Tolerance Can Be Induced to Immunogenic Class IIPeptides.
￿
To
determine whether autoreactive T cellsagainst immunogenic
MHC peptides were capable ofbeing inactivated during on-0
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Figure 5.
￿
Did 61-85 competitively inhibits the Ak-restricted response of
a T cell hybridoma to p20-35 from HEL. Results are expressed as % inhi-
bition; i.e., 100 x cpm obtained with HEL 20-35 + MHC peptide/cpm
obtained with HEL 20-35. The following peptides were tested in this in-
hibition assay: Dd 61-85 ("), Ld 61-72 (A), Ld 61-85 (p), and HEL p46-
61 (O) (used as positive control). The responses to p20-35 ranged from
89,134 to 101,443 cpm.
togeny, neonatal B10.A mice were injected with peptide Al
1-16 and tested 2 mo later for their capacity to develop a T
cell response against this pe~tide. As shown in Fig. 6, neo-
natal injection of peptide AO 1-16 resulted in complete un-
responsiveness to this peptide at 8 wk of age, showing that
there is no barrier to tolerance induction by this (or presum-
ably other) MHC peptide(s). The self-reactive T cells we have
detected, therefore, have managed to escape deletion or inac-
tivation.
Discussion
It is generally accepted that autoreactive T lymphocytes
recognizing self-antigen/MHC complexes are inactivated
during ontogeny (12-14) . Therefore, it would be expected
that all potential self-determinants, self-peptides that bind
MHC with high affinity, would not be immunogenic owing
to the clonal deletion ofinactivation of corresponding T cells.
The data presented in this article clearly show that this is
not the case. Certain class I- and class II-derived peptides
can bind with high affinity to self-class II molecules and also
induce potent T cell proliferative responses. Class I peptides
have previously been shown to interact with allogeneic class
I molecules in CTL recognition (15-17), but this is the fast
instance ofclass I peptide presentation by class II molecules
to self-reactive T cells. Several groups have recently provided
direct evidence that endogenous peptides can interact with
class II MHC molecules within the Golgi compartment and
subsequently be presented at the cell surface of APC in the
context of class II MHC (18, 19) . But was this also true for
peptides from self-MHC molecules themselves? The feasi-
bility of such functional interactions was suggested by Saskia
de Koster et al. (20), who obtained T cell clones from human
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Table 1.
￿
Dd 61-85 Induces T Cell Prolferative Responses in
B10.BR and CBA Mice But Not in B10.A Mice
Ia
Results are expressed as cpm obtained with cells stimulated in vitro with
Dd61-85. Each group represents six mice tested individually. The posi-
tive control responses to PPD ranged from 130,000 to 158,480 cpm.
The background values (cells + medium alone) ranged from 1,500 to
2,860 cpm.
peripheral blood that recognize an HLADR3 peptide, using
another self-class II MHC molecule as restriction element,
DPw3. In related work by Murphy et al. (21), an antibody
was raised that seems to recognize a fragment from a class
II E molecule in place within the binding groove of class
II A molecules. Most pertinently, they reported that such
complexes with this one peptide represent >10% of the total
surface A molecules. It appears, therefore, that abundant op-
portunity exists for the binding and presentation of self-class
II peptides.
Some self-MHC peptide-reactive T cells may escape toler-
ancebecause the potentially immunogenic determinants they
recognize fail to make an impact on the T cell repertoire.
a
U
30000
20000
10000
0
MHC peptide concentration (NM)
Figure 6.
￿
Neonatal injections of AkO 1-16 result in complete unrespon-
siveness to this peptide in adult mice. The proliferative responses ofthree
tolerized (O) and three control (") mice tested individually t SD are
indicated. The open squares represent thecpm ± SD obtained with normal
mice in response to MEM. The response to HEL of three adult mice neo-
natally tolerized with A~ 1-16 was 116,232 ± 18,423 cpm.
Mice Haplotype K Aa AO Eo Es D
T cell.
to Dd
response
61-85
cpm ± SD
B10.A H-2' k k k k k d 1,600 ± 660
B10.BR H-2k k k k k k k 18,200 ± 1,500
CBA/J H-2k k k k k k k 28,350 ± 2,120It has been shown recently that T cells specific for minor
determinants on a foreign antigen can escape tolerance in-
duction (22). This evasion apparently is based upon ineffec-
tive processing in vivo, and a resulting failure to assemble
enough complexes of the minor or cryptic determinant and
the MHC molecule. T cells specific for such cryptic deter-
minants are, not activated during immunization with the na-
tive antigen, although the determinant in the form of the
peptide may bind strongly to the MHC and induce excellent
T cell responses. It could have been proposed that the self-
MHC peptides used in this work were not capable of toler-
ance induction during ontogeny because of competition by
other self-peptides that bound to MHC with higher affinity
(23). However, such a competitiveblocking mechanism would
now seem unlikely, given that these MHC peptides bind with
high affinity compared with HEL p46-61 (Figs. 4 and 5).
Apparently, the blockin tolerance induction is rather the re-
sult of incomplete antigen processing. Accordingly, there is
a similar dominance hierarchy among determinants con-
stituting the MHC molecule as for any other antigen: some
determinants will be made readily available, via processing,
for presentation to T cells, while others never become avail-
able and remain cryptic. Therefore, it would have been
predicted that those class II peptides that are not cryptic de-
terminants would have had the capacity to induce neonatal
tolerance, as we show by experimental manipulation in Fig.
6. With respect to the five polymorphic Ak peptides exam-
ined in this work, however, we were unable to find any binding
peptides that had induced self-tolerance. Only the two NH2-
terminal peptides Aa 1-18 and Ak 1-16 bound to self-MHC
and they had not induced neonatal tolerance.
Since it has been demonstrated that some endogenously
produced MHC peptides have continuous access to the class
II binding sites, we must assume that Aa 1-18 and Ak 0 1-16,
found to be strongly immunogenic, are different and pre-
sumably poorly processed. This failure of these MHC deter-
minants to influence the developing repertoire may be attrib-
uted to their position in themolecule. The three-dimensional
model of class II MHC proposed by Brown et al. (24) shows
that the NH2 termini are part of the 0 pleated sheets, which
may be protected in the nativemolecule from proteolysis by
the a-helices that reside on top of them. A similar failure
to induce tolerance by a self-protein has been recently de-
scribed by Stockinger and Lin (25). In this case, presentation
of the pro-C5 self-peptide in the context of class II MHC
also did not appear efficient enough in vivo to ensure induc-
tion of tolerance to this self-component. Another possible
alternative is that pro-C5 as well as class II peptides resulting
from self-processing appear in a cell compartment where they
might preferentially interact with class I MHC, leaving a
suboptimalconcentration ofdeterminants for the class II pre-
sentation pathway.
In contrast to these cases of presumed difficulties in pro-
cessing and presentation, the example of the class I-derived
peptide from Dd, amino acids 61-85, demonstrates that pro-
cessing of some portions of MHC molecules occurs regu-
larly. Furthermore, processing of this self-MHC molecule
results in the induction of tolerance. In the B10.A mouse,
Dd peptide 61-85, which we show binds to Ak (Fig. 5),
cannot induce an immune response because presumably the
Dd 61-85 peptide/Ak complex induced tolerance during de-
velopment. An analogously positioned peptide from the a2
helix, Dd 148-162, induces neither a response nor tolerance
because it does not bind to class II molecules. Class I MHC
molecules, as was shown previously for class II, are also
processed into peptides thatcan interact efficiently with class
II MHC to activate T helper lymphocytes for the induction
of cytotoxic T cells. Our data suggest that Dd 61-85 repre-
sents an available determinant on class I MHC molecules in
that it induces complete tolerance when present as a self-
component in the thymus. It is noteworthy that its counter-
part on the Ld molecule (Ld 61-85) was found to be clearly
immunogenic in a self-context. This difference in neonatal
tolerance induction may be attributed to the fact that the
Ld molecule is displayed at much lower concentrations than
the Dd molecule (26).
It is now generally accepted that the T cell repertoire is
shaped by both positive and negative selection resulting from
recognition of self-molecules associated with self-MHC. Al-
though no direct evidence is currently available, itis possible
that self-MHC molecules include a set of determinants of
profound importance in the acquisitionof the repertoire and
its subsequentregulation, as has beenproposed by Kourilsky
et al. (4). Our data strongly suggest that both class I and
class II self-MHC molecules are processed into fragments that
can be presented in the context of intact class II molecules
at the surface of APC. Autoreactive T cells capable of recog-
nizing the "immune-self' complexes (which include portions
of Ig, TCR, and MHC molecules) presented during devel-
opment are deleted or inactivated within the thymus. How-
ever, some self-MHC peptide-reactive T cellsescape elimina-
tion because certain complexes are present at subtolerogenic
concentrations, at least in the compartment in which the MHC
becomes loaded with peptides. This incomplete tolerance to
self-components should normally be no cause for concern since
minor determinants are generally not presented, whether they
are derived from foreign or self-molecules. However, under
conditions of upregulation of MHC display, tissue damage,
or increased lymphokine secretion (or any combination of
circumstances), potentially autoreactive T cells may become
involved in autoimmune disease. Despite this potential, the
system has evolved to not eliminate all self-reactive T cells,
because to do so presumably would have led to excessive
purging of the T cell repertoire.
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